scholarly journals Macrophage Activation Syndrome in a Child with Systemic Juvenile Rheumatoid Arthritis

2005 ◽  
Vol 20 (4) ◽  
pp. 695 ◽  
Author(s):  
Mina Hur ◽  
Young Chul Kim ◽  
Kyu Man Lee ◽  
Kwang Nam Kim
Keyword(s):  
Rheumatoid Arthritis ◽  
Juvenile Rheumatoid Arthritis ◽  
Macrophage Activation Syndrome ◽  
Macrophage Activation ◽  
Activation Syndrome

Macrophage activation syndrome with acute hepatitis E during tocilizumab treatment for rheumatoid arthritis

2015 ◽  
Vol 82 (4) ◽  
pp. 278-279 ◽  
Author(s):  
Marie Leroy ◽  
Guillaume Coiffier ◽  
Charlotte Pronier ◽  
Louise Triquet ◽  
Aleth Perdriger ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Acute Hepatitis ◽  
Macrophage Activation Syndrome ◽  
Macrophage Activation ◽  
Hepatitis E ◽  
Acute Hepatitis E ◽  
Activation Syndrome

scholarly journals Macrophage Activation Syndrome as Onset of Systemic Lupus Erythematosus: A Case Report and a Review of the Literature

2015 ◽  
Vol 2015 ◽  
pp. 1-4 ◽  
Author(s):  
Guido Granata ◽  
Dario Didona ◽  
Giuseppina Stifano ◽  
Aldo Feola ◽  
Massimo Granata
Keyword(s):  
Rheumatoid Arthritis ◽  
Systemic Lupus Erythematosus ◽  
Case Report ◽  
Lupus Erythematosus ◽  
Macrophage Activation Syndrome ◽  
Macrophage Activation ◽  
Treatment Options ◽  
Review Of The Literature ◽  
Systemic Lupus ◽  
Activation Syndrome

Macrophage activation syndrome (MAS) is a potentially fatal condition. It belongs to the hemophagocytic lymphohistiocytosis group of diseases. In adults, MAS is rarely associated with systemic lupus erythematosus, but it also arises as complication of several systemic autoimmune disorders, like ankylosing spondylitis, rheumatoid arthritis, and adult-onset Still’s disease. Several treatment options for MAS have been reported in the literature, including a therapeutic regimen of etoposide, dexamethasone, and cyclosporine. Here we report a case of 42-year-old woman in whom MAS occurred as onset of systemic lupus erythematosus.

Sign in / Sign up

Export Citation Format

Share Document